Deerfield's Jim Flynn on healthcare investing, ‘LPs are drinking from a firehose’ in PE fundraising Morning Hubsters!
There’s an anecdote going around about private equity fundraising. Sources have told me somewhere in the range of 50 percent to 80 percent of existing GPs are back in the market fundraising. Despite everything going on in the world — inflation, supply chain disruptions, Russia’s invasion of Ukraine — LPs are beset with jammed fundraising pipelines.
“Every LP is drinking out of a firehose,” a placement agent told me recently. “They’re having to make decisions on the fly, who to re-up with and who not to re-up with. It’s not that they don’t want to re-up, but there’s a finite amount of capital.”
The jammed fundraising market is coming from established firms hitting the market quicker than expected, with larger funds and new products. It’s unusual, these days, for a successful firm to have just one flagship fund — so many GPs have expanded into ancillary lines of business like credit, or small-cap funds, or pools that target specific strategies.
Even with the frenetic pace of fundraising, LPs apparently can’t get enough private equity. A Preqin report this morning shows that 86 percent of the more than 350 LPs surveyed in November planned to invest the same or more in private equity. These findings are in line with other surveys in recent months that have shown no waning interest in the asset class.
Healthcare: PE Hub’s Aaron Weitzman interviewed Jim Flynn, managing partner at Deerfield Management Co, as part of its ongoing series on healthcare investing. Flynn outlined the firm’s approach to healthcare investing. Check it out here on the Hub.
Here's a sample:
“Inflation in salaries for healthcare workers is doubling costs and is super high, due to supply/demand imbalance for workers,” said Flynn.
Recently trained nurses help only to an extent. “The issue is they haven’t been trained within a hospital system the same way they normally would be, so they are less efficient,” he said. “Even though there is new supply, it’s not relieving the problem.”
More time: Banneker Partners, formed by an ex-Vista Equity executive, is eyeing a process for more time and capital with its pre-fund asset Linq, which provides software and services to school districts.
Banneker wants to move Linq into a continuation fund in a deal that could be valued up to $500 million. The deal would provide early pre-fund investors with liquidity, a source told Buyouts. Read here for more information.
That’s it for me! Hit me up with tips n’ gossip, feedback or book recommendations at [email protected] or find me on LinkedIn.
Read the full wire commentary on PE Hub ...
Also of note (may require subscriptions) EQT, Europe’s second-biggest private equity firm according to the PEI 300, hopes to tap into Asia’s burgeoning private wealth opportunity with its €6.8 billion acquisition of Baring Private Equity Asia. (Private Equity International, Financial Times, Wall Street Journal)
KKR has raised $17 billion for its fourth infrastructure fund, exceeding its initial $12 billion target by more than 40 percent. (Infrastructure Investor)
Värde Partners, a long-time investor in credit and distressed markets, rolled out a 14th flagship offering targeted to bring in $2 billion. (Buyouts) During a period when many investors are inundated with re-up opportunities, finding the time and financial capacity to build new GP relationships can prove challenging. Innchul Oh, a senior manager for private equity at Hyundai Marine & Fire Insurance, is among those attempting to strike a careful balance. (Private Equity International)
"Trafigura has held discussions with Blackstone about an equity investment of up to $3bn, as the privately owned commodity trader seeks to broaden its sources of funding." (Financial Times, Bloomberg)
"Asset manager Neuberger Berman has collected $1.95 billion for a debut fund to sponsor special-purpose acquisition companies, or SPACs, alongside CC Capital Partners, a private investment firm formed and led by ex-Blackstone Inc. dealmaker Chinh Chu." (WSJ Pro)
"Riding the pandemic waves: How private equity strategies are evolving" (Consultancy.uk)
They said it “There is an ongoing revolution that is occurring in drug discovery right now. Every disease is a finite puzzle.” — Jim Flynn, managing partner at Deerfield Management Co., on the firm’s approach to healthcare investing. Today's letter was prepared by Chris Witkowsky Subscribe now to get full, unlimited access to all PE Hub content, including every PE Hub Wire article. Please visit Buyouts for the latest insight into LP activity and Venture Capital Journal for comprehensive coverage and analysis of what’s happening in VC. To update your PE Hub email preferences, or to unsubscribe, click here. |